Announcement of Fortune Magazine ranking of America's Most Innovative Companies for 2023. University Hospitals was named to the list as No. 1 among health systems in Ohio for innovation culture. Among all industries and all categories (culture/process/product), UH ranked No. 205.
Announcement that NeuRx ® Diaphragm Pacing System, pioneered by University Hospitals and Case Western Reserve University in Cleveland, received FDA premarket approval. The system helps spinal cord injured patients breathe without a mechanical ventilator. Co-inventor Raymond Onders, MD, has implanted the system more than anyone else, and he travels the world teaching other doctors how to do it.
University Hospitals ranked #1 in Ohio for its online reputation in a recently released report from Reputation. It was also ranked 17th among the 30 largest U.S. health systems.
Harrington Discovery Institute Center for Brain Health Medicines at University Hospitals and the Alzheimer's Drug Discovery Foundation (ADDF) announce a joint request for proposal for the 2023 ADDF-Harrington Scholar Award. The ADDF-Harrington Scholar Award is designed to accelerate the translation of innovative research that could treat, prevent, slow, or reverse Alzheimer's disease or related dementias.
A study, co-led by University Hospitals Harrington Heart & Vascular Institute, could lead to the first FDA approval of a therapy giving thousands of patients hope for an alternative to amputation.
University Hospitals and The Diabetes Link will develop a financial and health insurance literacy video toolkit with the goal of empowering people with type 1 diabetes and improving their health outcomes.
Sadeer Al-Kindi, MD, received the American College of Cardiology’s prestigious Young Investigator Award at the ACC’s annual meeting recently held in New Orleans. The bulk of Dr. Al-Kindi’s research focuses on how environmental and socioeconomic factors impact heart health.
Announcement that the Patient-Centered Outcomes Research Institute (PCORI) tapped University Hospitals (UH) as one of 42 health systems nationwide to carry out a pioneering initiative to accelerate the implementation of practice-changing research results in clinical care to improve patients’ outcomes.
The NFL Physicians Society (NFLPS) awarded the Arthur C. Rettig Award for Academic Excellence to Dr. James Voos, Head Team Physician for the Cleveland Browns and NFLPS Board Vice President.
Cardiovascular medicine, hematology and pulmonary medicine may soon have the first-ever therapies to correct poor tissue oxygenation, a key driver of disease in millions, including peripheral artery disease, sickle cell disease, heart failure, stroke, emphysema and many others. The breakthrough follows a landmark discovery from investigators at Harrington Discovery Institute at University Hospitals (UH) and Case Western Reserve University School of Medicine. The research team showed that a modified version of hemoglobin, termed S-nitrosohemoglobin, senses areas with insufficient oxygen, and then restores blood flow for oxygenation. The study recently published in PNAS.
University Hospitals (UH) is investing $25.5 million to enhance UH Lake West and TriPoint medical centers this year, and align key services to ensure the highest quality of care for Lake County residents. The investments build on UH’s promise to expand and enhance services when Lake Health officially joined the UH health system in April 2021.
The Oxford-Harrington Rare Disease Centre (OHC), a partnership of the University of Oxford and Harrington Discovery Institute at University Hospitals (UH), is hosting a virtual event on Monday, Feb. 27, 2023, in honor of the upcoming Rare Disease Day, which is celebrated across the globe on February 28 every year.
For the second consecutive year, Forbes recognized University Hospitals (UH) as one of America’s Best Large Employers. UH earned the first spot among all health systems in Ohio. UH ranked 81st in the nation among businesses nationally with 1,000 or more employees. The recognition is based on independently conducted employee surveys.
A large international clinical study finds that patients with large strokes had a dramatically better recovery after endovascular thrombectomy plus medical management than patients receiving only standard medical management.
The study was published Feb. 10 in the New England Journal of Medicine to coincide with its presentation at the International Stroke Conference in Dallas.
The Board of Ohio Commission on Minority Health has appointed Celina Cunanan, MSN, APRN-CNM, Chief Diversity, Equity & Belonging Officer for UH, as Vice Chair of the Commission's board of directors.
In the journal Gastroenterology, researchers from University Hospitals and Case Western Reserve University School of Medicine in Cleveland publish a review of studies about the microbiome's role in disease and discuss data from clinical trials involving individuals with digestive issues and Crohn's disease treated with a probiotic formulation. Results showed the formulation reduced severity and frequency of overall GI symptoms and positively modulated specific symptoms.
University Hospitals (UH) Lake West Medical Center has been designated as a provisional Level 3 Trauma Center by the state of Ohio, based on consultation from reviewers of the American College of Surgery Verification, Review, and Consultation Program for excellence in trauma centers. The Program is designed to help hospitals evaluate and improve trauma care as well as provide objective, external review of institutional capability and performance. This is accomplished by an on-site review and assessment of the hospital’s commitment, readiness, resources, policies, patient care, performance improvement and other features.
The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals in Cleveland have granted an ADDF-Harrington Scholar Award to Christiane Wrann, PhD, DVM, Associate Professor in Medicine at the Cardiovascular Research Center and the McCance Center for Brain Health at Massachusetts General Hospital and the Harvard Medical School in Boston. Dr. Wrann will receive funding and drug development guidance to help advance her research towards potential new therapies for patients suffering from Alzheimer’s disease.
Announcement of the addition of Goutham Rao, MD, FAHA, to the U.S. Preventive Services Task Force (Task Force) to serve a four-year term, beginning this month. Dr. Rao will join fellow experts from primary care and prevention-related fields to rigorously review evidence and evaluate the benefits and harms of preventive services. The Agency for Healthcare Research and Quality (AHRQ) convenes the Task Force and provides scientific, administrative, and dissemination support.
Health article about how the holidays can add stress to your life, and left unchecked, the stress and anxiety can be detrimental to physical and mental health, including heart health.
University Hospitals (UH) today announced the completion of the first arthroscopic surgeries in Ohio, and amongst the first ever, using the new ArthroFree® Wireless Camera System. ArthroFree is the first wireless surgical camera system to receive market clearance from the U.S. Food and Drug Administration for use in broad endoscopic applications including arthroscopy.
University Hospitals (UH) is a leader in the national healthcare transformation focusing on providing proactive well-care that is as robust as the reactive sick-care system of treating disease. This approach to well-being is at the root of a new continuing education opportunity now being offered to all UH caregivers.
Announcement of a gift to University Hospitals Samaritan Medical Center, in Ashland, Ohio, from the Samaritan Hospital Foundation. The foundation has awarded an unprecedented $10 million grant. The gift supplements the Foundation’s annual support of the hospital which averages $2 million each year and promises to impact patient care and services for decades to come.
After statins, the next leading class of medications for managing cholesterol are PCSK9 inhibitors. These highly effective agents help the body pull excess cholesterol from the blood, but unlike statins, which are available as oral agents, PCSK9 inhibitors can only be administered as shots, creating barriers to their use.
In its most recent Community Benefit Report covering 2021, University Hospitals (UH) showcases recent examples of its continued effort to address health and economic disparities in Cleveland and Northeast Ohio. Over the past 10 years, UH has invested $3.5 billion in community benefit expenditures, and in 2021 alone, the health system’s community benefit expenditures totaled $531 million.
New research published in the Journal of the American College of Cardiology shows the use of drug-coated balloons is an optimal approach compared to bare metal stents in treating femoropopliteal lesions.
Thousands of people have new hope for treatment of thoracic aortic arch disease and UH Harrington Heart & Vascular Institute is at the forefront of studying the safety and efficacy of this new procedure.
Researchers at University Hospitals (UH) Seidman Cancer Center in Cleveland, Ohio and a biotech start-up company have developed a streamlined way to manufacture CAR T-cells for immunotherapy treatment in just 24 hours – an improvement over the team’s previous benchmark of eight days and commercial suppliers that typically take three weeks. The team is one of the first in the country to test this manufacturing approach.
Announcement that the Design Management Institute (dmi) recognized University Hospitals Cutler Center for Men as the second-place recipient of its 2022 dmi Design Value Awards on Sept. 27, and the Service Design Network (SDN) named the center a finalist for the 2022 Service Design Network Award in the Professional Non-Profit/Public Sector category on Oct. 13.
A team at University Hospitals in Cleveland aims to unearth potential immunologic mechanisms and understanding of COVID-19 upon long-term consequences and outcomes thanks to a grant from the American Lung Association.
University Hospitals in Cleveland has received national recognition for its care of patients with uncontrolled blood pressure, diabetes, heart disease, and stroke.
Announcement of transformational support from Cleveland community leaders Michael and Grace Drusinsky will benefit advanced orthopedic and sports medicine care at University Hospitals. In recognition, the system has renamed its nationally recognized sports medicine program in their honor: UH Drusinsky Sports Medicine Institute.
A nanoparticle therapy developed by investigators at University Hospitals (UH) and Case Western Reserve University targets overactive neutrophils, a specific kind of white blood cell, to prevent almost all types of blood clots while causing no increased risk for bleeding. The preclinical findings, published in Science Translational Medicine, may lead to safer ways to care for patients impacted by blood clots. According to the Centers for Disease Control and Prevention (CDC), roughly 900,000 people in the U.S. suffer from life-threatening blood clots each year.
UH Harrington Heart & Vascular Institute has a rich history of providing the highest level of care for patients. Continuing as leaders in this field and elevating cardiac surgery patient care to a new level, UH announces the addition of Rakesh Arora, MD, PhD, FRCSC, FACS, a world leader in perioperative care and management of cardiac surgery patients.
University Hospitals in Cleveland will receive GI Genius intelligent endoscopy modules, which use artificial intelligence, as part of an award through the Medtronic Health Equity Assistance Program for colorectal cancer screening. This program, sponsored by Medtronic and Amazon Web Services, donates AI-assisted colonoscopy technology to facilities providing for medically underserved communities with either low CRC screening rates or where access to this cutting-edge technology is not currently available.
The Center for Disease Control’s National Center for Immunization and Respiratory Diseases has awarded University Hospitals of Cleveland a sizable grant to support its assignment as a study site in the United States Flu Vaccine Effectiveness Network.
Announcement about Randy Vince, Jr., MD, MS, joining University Hospitals (UH) in Cleveland as the inaugural Minority Men’s Health Director for UH Cutler Center for Men and as a faculty member of the system's Urology Institute and UH Seidman Cancer Center.
Researchers at University Hospitals, with support from an American Heart Association® grant, will work to better understand how to successfully treat Black women diagnosed with depression who are also at risk for high blood pressure.
Many therapeutics for asthma and other obstructive lung diseases target the β2-adrenergic receptor (β2AR), a G protein-coupled receptor (GPCR) that rapidly supports airway relaxation when stimulated. Yet, overuse of these agents is associated with adverse health outcomes, including death, which has limited their utility as frontline therapies. Now, a mouse model study published in today’s issue of Molecular Cell, from investigators at University Hospitals (UH) and Case Western Reserve University, identifies a novel strategy to isolate the beneficial effects of β2AR stimulation. This suggests a new therapeutic approach to airway diseases as well as numerous other conditions involving the aberrant function of GPCRs.
With the support of Harrington Discovery Institute at University Hospitals (UH), an ophthalmic therapeutic dubbed KIO-301, which was initially developed by Richard Kramer, PhD, at the University of California, Berkeley (UCB), has successfully been granted approval to start a Phase 1b, first-in-human clinical trial. Currently under the stewardship of Kiora Pharmaceuticals, Inc., (NASDAQ: KPRX) via a license with UCB, Inc., the drug is intended to restore lost vision in patients with Retinitis Pigmentosa (RP)--a rare, genetic eye disease that causes severe loss of functional vision and affects an estimated 100,000 people in the U.S.
Announcement that University Hospitals in Cleveland appointed Scott Sasser, MD, FACEP, as Chief Physician Executive and President, University Hospitals Medical Group and University Hospitals Physician Services; effective Aug. 1, 2022,
Announcement of annual hospital ranking from US News & World Report, which recognized University Hospitals Cleveland Medical Center as a Best Hospital for 2022-2023. UH Cleveland Medical Center ranked in four of 15 adult specialties, and is ranked third among all hospitals in Ohio.
Several hospitals in the University Hospitals health system have been recognized by the American Heart Association (AHA) for their quality stroke care. The American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Quality Achievement Awards, achieved by UH medical centers, recognizes their commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
Announcement of the American Hospital Association (AHA), the premier national trade association representing more than 5,000 hospitals and health systems, selecting University Hospitals health system as the 2022 winner of its most prestigious honor: the Quest for Quality Prize.